| 2006 (1st) |
Calcutta |
Dr. YK Chawla |
Hepatic Fibrosis-Basic Science to Therapy |
— |
| 2007 (2nd) |
Pattaya |
Dr. C Pramoolsinsap |
The Innovation in Chronic Hepatitis B Treatment |
1st APASL HBV Conference |
| 2008 (3rd) |
Cairo |
Dr. G Shiha
Dr. A Ibrahim |
Liver Fibrosis |
1st APASL Liver Fibrosis Conference |
| 2008 (4th) |
Bali |
Dr. L Lesmana |
Hepatocellular Carcinoma |
1st APASL HCC Conference |
| 2009 (5th) |
Istanbul |
Dr. AK Dökmeci |
Non Responders |
— |
| 2009 (6th) |
Karachi |
Dr. S Hamid
Dr. W Jafri |
Acute Liver Failure : Asian-Pacfic Perspectives |
1st APASL ACLF Conference |
| 2010 (7th) |
Chiba |
Dr. O Yokosuka |
HCV |
1st APASL HCV Conference |
| 2011 (8th) |
Beijing |
Dr. FS Wang |
Hepatitis B Virus |
2nd APASL HBV Conference |
| 2011 (9th) |
Jeju |
Dr. BC Yoo |
Hepatocellular Carcinoma |
2nd APASL HCC Conference |
| 2012 (10th) |
Ulaan baatar |
Dr. A Jazag |
HBV & HCV Dual Infection |
2nd APASL HCV Conference |
| 2012 (11th) |
Dhaka |
Dr. S Rahman |
HBV |
3rd APASL HBV Conference |
| 2013 (12th) |
Cebu |
Dr. D Payawal |
HCC |
3rd APASL HCC Conference |
| 2013 (13th) |
Jakarta |
Dr. R Gani |
NASH |
1st APASL NASH Conference |
| 2014 (14th) |
Cairo |
Dr. G Shiha |
Liver Fibrosis |
2nd APASL Liver Fibrosis Conference |
| 2014 (15th) |
Karachi |
Dr. Z Abbas |
HCV |
3rd APASL HCV Conference |
| 2014 (16th) |
Guangzhou |
Dr. JL Hou |
HBV |
4th APASL HBV Conference |
| 2015 (17th) |
Yerevan |
Dr. H Ghazinyan |
HBV |
5th APASL HBV Conference |
| 2015 (18th) |
New Delhi |
Dr. BC Sharma |
HCV |
4th APASL HCV Conference |
| 2016 (19th) |
Busan |
Dr. KH Han |
Liver Cirrhosis |
1st APASL Liver Cirrhosis Conference |
| 2016 (20th) |
Kaohsiung |
Dr. WL Chuang |
HCV |
5th APASL HCV Conference |
| 2016 (21st) |
Beijing |
Dr. Lai Wei |
HBV |
6th APASL HBV Conference |
| 2017 (22nd) |
Nagasaki |
Dr. Hiroshi Yatsuhashi |
HCC |
4th APASL HCC Conference |
| 2017 (23rd) |
Ulaanbaatar |
Dr. Oidov Baatarkhuu |
HCV and coinfection |
6th APASL HCV Conference |
| 2017 (24th) |
Cairo |
Dr. Gamal Shiha |
HCV |
7th APASL HCV Conference |
| 2018 (25th) |
Yokohama |
Dr. Shuichiro Shiina |
HCC |
5th APASL HCC Conference |
| 2018 (26th) |
Taipei |
Dr. Rong-Nan Chien |
HBV in Asia-Pacific |
7th APASL HBV Conference |
| 2018 (27th) |
Kuala Lumpur |
Dr. Rosmawati Mohamed |
HCV |
8th APASL HCV Conference |
| 2018 (28th) |
Istanbul |
Dr. Necati Ormeci |
Non-Responder |
— |
| 2018 (29th) |
Beijing |
Dr. Gui-Qiang Wang |
Autoimmune |
— |
| 2019 (30th) |
Tokyo |
Dr. Atsushi Tanaka |
Liver Immunology and Genetics |
— |
| 2019 (31st) |
Baku |
Dr. Gulnara Aghayeva |
Hepatitis Delta |
— |
| 2020 (32nd) |
Guangzhou |
Dr. Xiaolong Qi |
Portal Hypertension |
— |
| 2021 (33rd) |
Osaka |
Dr. Norifumi Kawada |
Molecular and Cellular Biology |
— |
| 2021 (34th) |
Tokyo |
Dr. Mitsuhiko Moriyama |
Oncology |
1st APASL 2020 Oncology
6th APASL HCC Conference |
| 2022 (35th) |
Beijing |
Dr. Hong You |
Liver Fibrosis |
— |
| 2022 (36th) |
Taipei |
Dr. Chun-Jen Liu |
Paradigm Shift of HCC Management: Across Viral to Steatogenic Carcinogenesis |
— |
| 2022 (37th) |
Cairo |
Dr. Gamal Shiha |
Liver Fibrosis: Liver Fibrosis in the era of MAFLD |
— |
| 2022 (38th) |
Takamatsu |
Dr. Tsutomu Masaki |
HCC：Clinical and basic research |
— |
| 2022 (39th) |
Wuhan |
Dr. Qin Ning |
Critical Care in Hepatology ACLF |
— |
| 2022 (40th) |
Istanbul |
Dr. Ibrahim Halil Bahcecioglu |
Hepatotoxicity |
— |
| 2022 (41st) |
Yerevan |
Dr. Hasmik Ghazinian |
NAFLD/NASH: Non-Infection Epidemic in XXI |
— |
| 2022 (42nd) |
Guangzhou |
Dr. Jinjun Chen |
Image-guided Interventions in Liver Diseases |
— |
| 2022 (43rd) |
Manila |
Dr. Ian Homer Y. Cua |
Liver Cirrhosis and Its Complication |
— |
| 2023 (44th) |
Sendai |
Dr. Yoshiyuki Ueno |
Oncology |
— |
![The Asian Pacific Association for the Study of the Liver [APASL]](http://apasl.info/app-def/S-102/apasl/wp-content/themes/apasl/images/header/img_apasl_logo.png){kind=logo}